161 related articles for article (PubMed ID: 7279701)
1. Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy.
Ahlemann LM; Staab HJ; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):143-50. PubMed ID: 7279701
[TBL] [Abstract][Full Text] [Related]
2. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
3. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
Ahlemann LM; Staab HJ; Anderer FA
Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582
[TBL] [Abstract][Full Text] [Related]
4. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
5. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Takahashi K; Sasaki Y; Ohkura H
Gan To Kagaku Ryoho; 1984 May; 11(5):1056-63. PubMed ID: 6202246
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment.
Waalkes TP; Abeloff MD; Woo KB; Ettinger DS; Ruddon RW; Aldenderfer P
Cancer Res; 1980 Dec; 40(12):4420-7. PubMed ID: 6254646
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
Paulick R; Caffier H
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751
[TBL] [Abstract][Full Text] [Related]
8. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
Tondini C; Hayes DF; Gelman R; Henderson IC; Kufe DW
Cancer Res; 1988 Jul; 48(14):4107-12. PubMed ID: 3164256
[TBL] [Abstract][Full Text] [Related]
9. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
Machens A; Ukkat J; Hauptmann S; Dralle H
Arch Surg; 2007 Mar; 142(3):289-93; discussion 294. PubMed ID: 17372055
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of carcinoembryonic antigen (CEA) in the follow-up of patients with inoperable lung cancer undergoing polychemotherapy].
Coloni GF; Lococo A; Battaglia C; Crisci R; Di Ignazio D
Minerva Med; 1983 Mar; 74(13):695-8. PubMed ID: 6835558
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage?
Kawachi R; Nakazato Y; Takei H; Koshi-ishi Y; Goya T
Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):199-202. PubMed ID: 19457896
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer.
Iwanicki-Caron I; Di Fiore F; Roque I; Astruc E; Stetiu M; Duclos A; Tougeron D; Saillard S; Thureau S; Benichou J; Paillot B; Basuyau JP; Michel P
J Clin Oncol; 2008 Aug; 26(22):3681-6. PubMed ID: 18669452
[TBL] [Abstract][Full Text] [Related]
13. [Carcinoembryonic antigen (CEA) in patients with lung cancer: correlation with tumour extent and response to treatment (author's transl)].
Gropp C; Lehmann FG; Havemann K
Dtsch Med Wochenschr; 1977 Jul; 102(30):1079-82. PubMed ID: 891388
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
[TBL] [Abstract][Full Text] [Related]
16. Three-year follow-up of carcinoembryonal antigen levels in the serum of patients with breast cancer.
Lang BA; Kocent A; Nekulová M; Hlávková J
Neoplasma; 1984; 31(1):79-87. PubMed ID: 6700798
[TBL] [Abstract][Full Text] [Related]
17. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
20. [Determination of carcinoembryonic and carbohydrate antigens in the diagnosis of recurrences and metastases of rectal cancer].
Ozhiganov EL; Kuznetsova LF
Med Radiol (Mosk); 1986 Aug; 31(8):40-4. PubMed ID: 3462448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
